Cleveland Clinic Expands Global Access to Care by Appointing Five New In-Country Representatives

As part of its continued efforts to ensure greater access to quality care for patients around the world, Cleveland Clinic is broadening its network of in-country representatives to five locations: Canada, China, Colombia, Ecuador and Mexico. As one of the world’s top hospital systems – according to Newsweek’s World’s Best Hospitals 2022 list – Cleveland Clinic provides patients … Read More

Cleveland Clinic Trial Finds Six Widely Used Dietary Supplements Do Not Lower Cholesterol Compared with Either a Low-dose Statin or Placebo

Findings from a Cleveland Clinic trial show that six commonly used dietary supplements marketed for improving heart health did not lower “bad cholesterol” when compared to a low-dose cholesterol-lowering medication (also known as a statin) or placebo. The six supplements studied included fish oil, garlic, cinnamon, turmeric, plant sterols and red yeast rice. Results from … Read More

Cleveland Clinic Receives $12 Million NIH Grant to Investigate Use of Inflammatory Cytokines in Personalized Cancer Treatments

Cleveland Clinic’s Lerner Research Institute was awarded a five-year $12 million grant by the National Cancer Institute, part of the National Institutes of Health, to define how cytokines – proteins produced during immune response – regulate inflammation and interact with cells and molecules surrounding tumors. Delivering cytokines in immunotherapy can signal an immune response that … Read More

Cleveland Clinic Responds to Increased Global Demand for Quality Healthcare by Launching Cleveland Clinic Connected

Cleveland Clinic has launched a robust program of collaborative support to enable hospitals and healthcare organizations around the world to connect with the global health system’s clinical and operational experts to enhance patient care and distinguish themselves within their markets. The goal of the Cleveland Clinic Connected program is to build a global network of … Read More

Endowed Fund Will Create the Rich Family Chief Caregiver Chair

Robert and Melinda Rich, the Rich Family Foundation and the Dreamcatcher Foundation have made a joint gift of $5 million to Cleveland Clinic. The Rich Family Chief Caregiver Chair will be established with the endowed fund and will support key projects and innovative ideas identified by Cleveland Clinic’s Chief Caregiver Officer. Chief Caregiver Officer K. … Read More

University Hospitals and Cleveland Clinic Join Forces to Prevent Substance Misuse and Overdose Deaths by Hosting Drug Take Back Day on October 29

Substance misuse and unintentional overdose deaths continue as an epidemic across Northeast Ohio and the nation. Most misused prescription drugs are obtained from family and friends, often from a home medicine cabinet, according to The National Survey on Drug Use and Health. Unused or expired medications are best disposed of at an official disposal location. … Read More

Holzer Center for Cancer Care Announces Affiliation with Cleveland Clinic Cancer Center

Holzer Health System and Cleveland Clinic have announced a new formal affiliation between the Holzer Center for Cancer Care (HCCC) and Cleveland Clinic Cancer Center. This affiliation expands access to highly specialized cancer treatments, clinical resources, and clinical trials for patients in the southeastern Ohio and western West Virginia communities.   “This affiliation will provide … Read More

Cleveland Clinic and IBM Begin Installation of IBM Quantum System One

Cleveland Clinic and IBM have begun deployment of the first private sector onsite, IBM-managed quantum computer in the United States. The IBM Quantum System is to be located on Cleveland Clinic’s main campus in Cleveland.  The first quantum computer in healthcare, anticipated to be completed in early 2023, is a key part of the two organizations’10-year partnership aimed at fundamentally advancing … Read More

Multi-Center Study Sheds Light on Understudied Breast Cancer Type

A multi-center analysis of patients with invasive lobular carcinoma, or ILC — the second most common histological subtype of invasive breast cancer in the U.S. — showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma (IDC), or no … Read More